Next earnings date: 5 Dec 2025

Coloplast A/S – OTC:CLPBY
Coloplast A/S stock price today
Coloplast A/S stock price monthly change
Coloplast A/S stock price quarterly change
Coloplast A/S stock price yearly change
Coloplast A/S key metrics
Market Cap | 26.28B |
Enterprise value | 185.22B |
P/E | 3.50 |
EV/Sales | 6.85 |
EV/EBITDA | 21.61 |
Price/Sales | 6.04 |
Price/Book | 0.98 |
PEG ratio | N/A |
EPS | 17.62 |
Revenue | 24.98B |
EBITDA | 8.11B |
Income | 4.90B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 18.69% |
Oper. margin | 27.25% |
Gross margin | 67.59% |
EBIT margin | 27.25% |
EBITDA margin | 32.49% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeColoplast A/S stock price history
Coloplast A/S stock forecast
Coloplast A/S financial statements
Mar 2023 | 6.06B | 1.15B | 19.06% |
---|---|---|---|
Jun 2023 | 6.10B | 1.27B | 20.83% |
Sep 2023 | 6.22B | 1.22B | 19.74% |
Mar 2024 | 6.58B | 1.25B | 19.01% |
2025 | 28.94B | 585.66M | 2.02% |
---|---|---|---|
2026 | 31.40B | 651.23M | 2.07% |
2027 | 33.99B | 738.86M | 2.17% |
2028 | 36.81B | 858.36M | 2.33% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 93.43% |
---|
2020 | 16.97% |
---|---|
2021 | 17.9% |
2022 | 24.58% |
2023 | 26.45% |
2024 |
Mar 2023 | 35302000000 | 28.26B | 80.07% |
---|---|---|---|
Jun 2023 | 35087000000 | 28.59B | 81.5% |
Sep 2023 | 48159000000 | 30.86B | 64.08% |
Mar 2024 | 48140000000 | 31.94B | 66.35% |
Mar 2023 | 689M | -106M | -623M |
---|---|---|---|
Jun 2023 | 1.16B | -274M | -655M |
Sep 2023 | 1.88B | -8.30B | 6.46B |
Mar 2024 | -2.56B | -287M | 2.80B |
Coloplast A/S alternative data
Aug 2023 | 14,973 |
---|---|
Sep 2023 | 14,700 |
Oct 2023 | 14,700 |
Nov 2023 | 14,700 |
Dec 2023 | 15,692 |
Jan 2024 | 15,692 |
Feb 2024 | 15,692 |
Mar 2024 | 15,751 |
Apr 2024 | 15,751 |
May 2024 | 15,751 |
Jun 2024 | 15,930 |
Jul 2024 | 15,930 |
Coloplast A/S other data
-
What's the price of Coloplast A/S stock today?
One share of Coloplast A/S stock can currently be purchased for approximately $9.46.
-
When is Coloplast A/S's next earnings date?
Coloplast A/S is estimated to report earnings on Friday, 5 Dec 2025.
-
Does Coloplast A/S pay dividends?
Yes, Coloplast A/S pays dividends and its trailing 12-month yield is 11.06% with 93% payout ratio. The last Coloplast A/S stock dividend of undefined was paid on 5 Sep 2025.
-
How much money does Coloplast A/S make?
Coloplast A/S has a market capitalization of 26.28B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.33% to 27.03B US dollars.
-
What is Coloplast A/S's stock symbol?
Coloplast A/S is traded on the OTC under the ticker symbol "CLPBY".
-
What is Coloplast A/S's primary industry?
Company operates in the Healthcare sector and Medical Instruments & Supplies industry.
-
How do i buy shares of Coloplast A/S?
Shares of Coloplast A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Coloplast A/S have?
As Jul 2024, Coloplast A/S employs 15,930 workers, which is 1% more then previous quarter.
-
When Coloplast A/S went public?
Coloplast A/S is publicly traded company for more then 11 years since IPO on 13 Jan 2014.
-
What is Coloplast A/S's official website?
The official website for Coloplast A/S is coloplast.com.
-
How can i contact Coloplast A/S?
Coloplast A/S can be reached via phone at +45 49 11 11 11.
Coloplast A/S company profile:

Coloplast A/S
coloplast.comOTC
14,500
Medical Instruments & Supplies
Healthcare
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Humlebæk, 3050
CIK: 0001294325
ISIN: US19624Y2000
: